Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GlaxoSmithKline, LLC
Current Parent Company: GlaxoSmithKline
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $15,000,000
Year: 2013
Date: December 17, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Violation Description: The Maryland Attorney announced the state had recovered $15 million from GlaxoSmithKline, LLC, resolving allegations that the company engaged in improper marketing of the prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to treat diabetes.
Level of Government: state
Action Type: agency action
Agency: Maryland Attorney General
Civil or Criminal Case: civil
Facility State: Maryland
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.